Lung Cancers Withdrawn Phase 1 / 2 Trials for Nivolumab (DB09035)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Withdrawn1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02466568Study of Nivolumab in Combination With GM.CD40L Vaccine in Adenocarcinoma of the LungTreatment